VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.500
+0.110 (4.60%)
Dec 20, 2024, 4:00 PM EST - Market closed
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $36.88 million as of December 20, 2024. Its market cap has decreased by -18.45% in one year.
Market Cap
36.88M
Enterprise Value
-33.18M
1-Year Change
-18.45%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $36.88M, a decrease of -83.95%. That is a compound annual growth rate of -31.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 36.88M | 13.40% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spectral AI | 36.68M |
| SAB Biotherapeutics | 35.99M |
| FibroGen | 35.64M |
| Precision BioSciences | 35.29M |
| Movano | 35.27M |
| Actinium Pharmaceuticals | 34.94M |
| NEXGEL | 34.73M |
| Lantern Pharma | 34.62M |